Coston McIsaac & Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Coston McIsaac & Partners's MDT Position: Q2 2026 in Review
Coston McIsaac & Partners increased its Medtronic (MDT) stake by 4.6% in Q2 2026, buying an estimated $214K and bringing the position to 59,948 shares worth $4.69M. The position accounts for 0.94% of the portfolio, ranked #32.
Coston McIsaac & Partners first reported a position in MDT in Q2 2022 and has held it in 17 quarters since. The position peaked at $5.52M in Q4 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Coston McIsaac & Partners held 59,948 shares of Medtronic worth $4.69M as of Q2 2026.
- Coston McIsaac & Partners bought 2,650 Medtronic shares in Q2 2026, an estimated $214K.
- Medtronic made up 0.94% of Coston McIsaac & Partners's portfolio in Q2 2026, its #32 holding.
- Coston McIsaac & Partners first reported a position in Medtronic in Q2 2022 and has held it in 17 quarters since.
- Coston McIsaac & Partners's Medtronic position peaked at $5.52M in Q4 2025.
- 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.